Rocket Doctor Ai Inc.

Rocket Doctor Ai Inc.

TREIF
Rocket Doctor Ai Inc.US flagOther OTC
0.49
USD
+0.01
- -
36.62MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
0.01
Basic EPS, GAAP
-0.47
-0.45
-2.14
-0.61
-0.26
-0.17
-0.16
Free Cash Flow per Basic Share
-0.08
-0.31
-0.97
-0.24
-0.05
-0.1
-0.09
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.06
-0.1
-0.85
-1.5
-0.59
-0.21
-0.08
Tangible Book Value per Share
0.05
-0.04
0.02
-0.35
-0.05
0.02
-0.18
Basic Weighted Avg Shares
6
6
6
6
14
44
54
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
Operating Margin (%)
- -
- -
- -
- -
- -
-54,790.39
-1,585.6
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-14
-4
-4
-8
-9
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-68,731.51
-1,670.11
Working Capital
- -
- -
- -
-2
-1
1
-6
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
-2
-1
1
8
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
58
76
Market Capitalization
20
21
22

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1
3
1
Cash, Cash Equivalents & STI
1
2
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
7
Payables & Accruals
- -
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-536.43%
-207.41%
Free Cash Flow
- -
176.26%
499.95%
Net Income, GAAP
- -
80.38%
102.92%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.06
-0.04
-0.33
- -
-0.26
2024
-0.02
-0.07
-0.03
- -
-0.17
2025
-0.04
-0.04
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Essam Hamza
Full Time Employees
3
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
800 – 885 West Georgia Street Vancouver BC Canada V6C 3H1
IPO Date
Sep 1, 2021
Business
Rocket Doctor AI Inc. (CSE: AIDR; OTC: TREIF) develops and provides physician-built artificial intelligence solutions for healthcare professionals, patients, and medical education institutions. The company offers a suite of core products powered by its proprietary Global Library of Medicine (GLM), a clinically validated AI engine delivering over 92% accuracy on first diagnosis, recommended tests, x-rays, and billing codes; Rocket Doctor, an AI-powered digital health platform and marketplace functioning as a "Shopify for physicians" that enables clinicians to launch and manage virtual or hybrid practices with tools including Starship EMR for electronic medical records, video consultations, prescription management, lab requisitions, and patient portals; RD AI Connect for auto-triaging over 20 chief complaints to assess virtual care suitability; RD AI Health Voyager for generating concise patient history summaries; Medical Education Suite (MES) for AI-driven clinical training and assessments; and AI-Voice Nurse for voice-based care support and mental health assistance. Founded in 2018 and headquartered in Vancouver, British Columbia, Canada, with additional offices across Canada (Alberta, British Columbia, Ontario, New Brunswick) and the United States (California, New York, Minnesota), the company targets healthcare providers, medical schools, underserved rural/remote communities in Canada, and Medicaid/Medicare populations in the U.S., operating primarily in the advanced medical equipment and technology sector with a focus on business-to-business models. Recent developments include the April 2025 acquisition of Rocket Doctor Inc., which added scalable virtual care capabilities supporting over 300 clinicians and 700,000 patient visits, drove first-quarterly revenue of $0.5 million in Q2 2025, and expanded U.S. presence through partnerships such as virtual care with Central California Alliance for Health serving 450,000 Medi-Cal members and in-network status for New York's 6.9 million Medicaid beneficiaries; an August 2025 $4.23 million private placement to fund U.S. expansion and platform development; a name change from Treatment.com AI Inc. and ticker shift to AIDR in August 2025; and live deployment of MES to 240 University of Minnesota medical students in June 2025, validating new revenue streams in medical education.

Company News

APIChatGPT
  • Rocket Doctor Secures Funding to Drive U.S. Market Expansion and Product Innovation

  • Rocket Doctor AI to Present at the 2025 CANTech Letter Conference in Toronto

  • ROCKET DOCTOR AI INC. ANNOUNCES AUTOMATIC CONVERSION OF SPECIAL WARRANTS

  • Rocket Doctor Now In-Network with Maryland Medicaid & Medicare, Expanding Access for Vulnerable Populations

  • Rocket Doctor AI Inc Announces Closing of C$4.23m Over-Subscribed Non-Brokered Private Placement of Special Warrants and Units

  • CSE Bulletin: Name and Symbol Change - Treatment.com AI Inc. (TRUE)

  • Treatment.com AI Engages Market Maker

  • Treatment.com AI Announces Non-Brokered Private Placement of up to C$3 million of Special Warrants and Units

  • Treatment.com AI Engages Marketing Services Providers

  • Treatment.com AI Grants Stock Option and RSUs

  • Rocket Doctor Launches Virtual Care Program with Central California Alliance for Health to Expand Access for Medi-Cal Patients

  • Repeat: Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients

  • Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients

  • Treatment.com AI on front line of the quest to enhance healthcare system efficiency

  • Rocket Doctor, a Treatment.com AI company, Joins Larta Institute's 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care

  • Treatment.com AI and Rocket Doctor Celebrate Recognition from UC Berkeley, Harvard, and AARP for Leadership in Health Innovation

  • Treatment.com AI Grants Stock Options and RSUs

  • Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients

  • Treatment.com AI and Rocket Doctor Applaud US Health Secretary RFK Jr.'s Call for Greater Investment in Telehealth and AI-Driven Diagnostic Tools

  • Rocket Doctor Named Clinical Innovator of the Year at NEXUS 2025